ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 121 filers reported holding ANAPTYSBIO INC in Q4 2019. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $334,692 | +22.6% | 10,800 | +0.9% | 0.00% | 0.0% |
| Q3 2022 | $272,957 | -25.0% | 10,700 | -27.2% | 0.00% | 0.0% |
| Q1 2022 | $364,000 | -45.8% | 14,700 | -23.8% | 0.00% | -40.0% |
| Q4 2021 | $671,000 | -12.9% | 19,300 | -32.0% | 0.01% | -37.5% |
| Q3 2021 | $770,000 | +4.2% | 28,400 | -0.4% | 0.01% | +14.3% |
| Q2 2021 | $739,000 | +26.1% | 28,500 | +4.8% | 0.01% | +16.7% |
| Q1 2021 | $586,000 | -21.9% | 27,200 | -22.1% | 0.01% | -25.0% |
| Q4 2020 | $750,000 | +123.2% | 34,900 | +53.1% | 0.01% | +100.0% |
| Q3 2020 | $336,000 | -33.7% | 22,800 | +0.4% | 0.00% | -33.3% |
| Q2 2020 | $507,000 | +111.2% | 22,700 | +33.5% | 0.01% | +100.0% |
| Q1 2020 | $240,000 | -0.8% | 17,000 | +14.1% | 0.00% | 0.0% |
| Q4 2019 | $242,000 | – | 14,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $371,500,000 | 60.25% |
| Cormorant Asset Management, LP | 1,251,485 | $126,050,000 | 13.20% |
| BVF INC/IL | 594,397 | $59,868,000 | 7.22% |
| VHCP Management II, LLC | 282,550 | $28,458,000 | 6.82% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 812,484 | $81,833,000 | 3.22% |
| Iguana Healthcare Management, LLC | 40,000 | $4,029,000 | 2.62% |
| Perceptive Advisors | 756,387 | $76,183,000 | 2.52% |
| Cormorant Asset Management, LP | 135,000 | $13,597,000 | 1.42% |
| EAM Global Investors LLC | 21,734 | $2,189,000 | 1.12% |
| PFM Health Sciences, LP | 425,896 | $42,896,000 | 1.02% |